Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
Holders of 5% or more of LGVN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Longeveron Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Intracoastal Capital, LLC | 13G | 9.99%2.14M shares | New | Aug 15, 20251 filing | Aug 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Longeveron Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 20262:15 PM ET | Lincoln Alternative Strategies LLC | 13G/A | 0.00%0 shares | −6.09 ppfrom 6.09%Below 5% | Aug 13, 2025 | SEC |
| Aug 27, 20259:15 AM ET | Lincoln Alternative Strategies LLC | 13G | 6.09%1.18M shares | New | Aug 8, 2025 | SEC |
| Aug 15, 20254:47 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 9.99%2.14M shares | New | Aug 8, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Longeveron Inc. shares.
No Form 144 notices for Longeveron Inc. are on file.